Eporise 40000 Injection Substitute
Sanofi India Ltd
₹1550
(₹1550.0/ 1ml)
Biocon Ltd
₹10890
(₹2722.5/ 1ml)
Serum Institute Of India Pvt Ltd
₹5900
(₹5900.0/ 1ml)
Johnson & Johnson Pvt Ltd
₹13770
(₹13770.0 per unit)
Intas Pharmaceuticals Ltd
₹15247.5
(₹15247.5/ 1ml)

Patients may explore substitutes in the following scenarios:
Before you switch from Eporise 40000 Injection to another medicine, here are some important points to keep in mind:
Most substitutes contain the same active ingredient - RECOMBINANT HUMAN ERYTHROPOIETIN ALFA-40000IU, but the fillers, coating, or manufacturing quality may vary slightly.
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Eporise 40000 Injection is used to treat anemia caused by chronic kidney illness, cancer, and HIV infection. The detailed uses of Eporise 40000 Injection are as follows:
Eporise 40000 Injection is a blood hormone. It contains Recombinant Human Erythropoietin Alfa used to treat anaemia caused by chronic diseases and anaemia related to kidney disease, cancers, bone marrow disorders, chemotherapy, children and adults on dialysis, and in those due to undergo major bone surgery. Eporise 40000 Injection stimulates the bone marrow to produce more red blood cells. In addition, it also corrects any dysregulated erythropoiesis (RBC formation) and remedies the formation of any defunct precursors of RBC’s, paving the way for healthy red blood cell production. Clinically, Eporise 40000 Injection causes a direct increase in haemoglobin values and reduces the rates and requirement of blood transfusion.
RX